Products
Nuformix has a growing IP portfolio, fed by an aggressive product development pipeline. Our products represent new forms of existing drugs across a range of therapeutic classes.
Nuformix’s products represent important improvements over the current marketed drug form in terms bioavailability, and other key physical properties such as hygroscopicity or stability.
Nuformix’s lead products NX006 and NX007 are poised for market entry and the company is currently seeking commercialisation partners.